| Tag | Content |
|---|
EnhancerAtlas ID | HS091-27320 |
Organism | Homo sapiens |
Tissue/cell | HepG2 |
Coordinate | chr2:114002200-114004330 |
Target genes | |
TF binding sites/motifs | | TF | JASPAR ID | Coordinate | Motif Sequence | Strand | -Log10(p-value) |
| TFAP2C | MA0524.2 | chr2:114003789-114003801 | TGCCCTGGGGCA | + | 6.44 | | TFAP2C | MA0524.2 | chr2:114003789-114003801 | TGCCCTGGGGCA | - | 7.22 | | ZNF263 | MA0528.1 | chr2:114003184-114003205 | CTTCCCCTCCCTCTATCCTCC | - | 6.05 | | ZNF263 | MA0528.1 | chr2:114004074-114004095 | AGAGAAGAAGGGAGAGGGAGA | + | 6.16 | | ZNF263 | MA0528.1 | chr2:114003176-114003197 | CCTCCACCCTTCCCCTCCCTC | - | 6.49 |
|
| | Number of super-enhancer constituents: 4 | ID | Coordinate | Tissue/cell |
| SE_56015 | chr2:114001195-114003811 | u87 | | SE_65429 | chr2:114001316-114002484 | Pancreatic_islets | | SE_65429 | chr2:114004103-114004833 | Pancreatic_islets | | SE_67831 | chr2:114001195-114003811 | u87 |
|
| | Diseases: AD,Huntington,Obesity,Parkinson,Prostate cancer,Schizophrenia and Sleep disorder | | Number of disease enhancers: 4 | Chromosome | Start | End |
| chr2 | 114002873 | 114003559 | | chr2 | 114002460 | 114002572 | | chr2 | 114003125 | 114003274 | | chr2 | 114003409 | 114003491 |
|
| | Number: 2 | ID | Chromosome | Start | End |
| GH02I113243 | chr2 | 114001196 | 114003811 | | GH02I113246 | chr2 | 114004104 | 114005436 |
|
Enhancer Sequence | CCTACTCCAA TAGAGAATCC CAAAGAATTA CCCAATAAGC AGGTGGGGTC TTTAGACAGG 60
GATTTAGCCA GAGCCTCCCT CCTCTCTGAG GCTTCTGGGT AGGGGTATGA GAGTGAAATG 120
TGCCTCCAAG GCTGGTCTCA AACGCTTGAT GTGCATGGAA CTATCTGTTT CCCTCACTTG 180
GGTAGGTTCA TGCTACTGCC AAACCAGCAC CCTCTGCTAA AGGCCTCACC TTGGCTTCTC 240
TCTCTTCCTT CCCTCTGGCC AGTCTCTTGT GTCCTAGCAT CTGCAACAGC CATTGTATGG 300
GGCACAAAAG ATTTCCCTTC TAAGAAAGGA AATCTTGGTG TGCCTGATGT GTGAATGACA 360
GGGGCACAGC AGTTTGCTCT ATCCAGCTTC TTTTGGCTAA AGCACGACTG AGGTTTTTTT 420
TGTTTTTTTT TTTTGTTTTT TGAGACAGGG TCTCAATCTG TCACCCAGGC TAGAATGCAA 480
TGGGACAAGC TTGGCTCACT TCAAACTCTG CCTCCCAGGT TCAGGTGATT CTCCTGCCTC 540
AGCCTCCCGA GTAGCTGGGA TTACAAGCGT CTGCCACCAC ACCCGGCTAA TTTTTGCATT 600
TTTAGTAGAG ACAGGTTTCA CTCAGTTGGC CTGGCTGGTC TTGAGCCCCT GACCTCAAGT 660
GATCCGCCCA CCTTGGCCTC CCAAAGTGCT GGGATTACAG GCATCAGCCA CCATGCCCAG 720
CCAATGACTG ACTATTTTCT TTGGCCACCT AGAAAGCTAG CCGAGGTCAC TGGACCCTCT 780
GCTCTGTCTT GCTGGTTCAC CTTTGCTCCC TGCCCTGTCC AAGCCTGAGG CATATCCCTC 840
ACCCCCCTGG TCACTGGTTT TCTATCAGGT TTTAGCAGGT TCAAGTTGAA GCTTCTCCTC 900
ATGGACTCTG GAATCCTGAC CTTGCTTGGA TCCCCAGCCA GGTCCAACTT GTTAAGCTGA 960
GCCTCCTCTT CTGGGGCCTC CACCCTTCCC CTCCCTCTAT CCTCCAACTA GTTGCTTTGG 1020
CAGATCAACC GCCTGTGTCA GCATATCCTC CTCTTCTTGT TGTAGAAACT CTCTGCTCTC 1080
ATCTGCATGA AAAAGAATCT AGCTCTTTAA AACTCCATTC ATCTGTTACT TCCATCCAGG 1140
ACTCATCTCT TCTGGGACAC CACAACCCAT CACAGGAATC CCCTCTCCCT AGCCCAGCAA 1200
AGGATCATGC CTTTCCCTAA CTACTTCAGG AGGGGAGCCA GGGCTTTTCA CGGTTCAAAG 1260
AACAGTCCAG GTCCCTTTAC CTTGTCCAAC CAGGGCTCCT CCTAAATCCA CCTAAGGGTC 1320
AGAGCAGGGG GACAGGCACA CGTACACAGA GCTGACTGGA AGCTGTGGCA CAGAGGCATT 1380
TTTAATGGAA GTGGCTTTGC AGACTGGAAT CTGTGACTGC ATCAGCTCAG AAGCAGGCCT 1440
TTGCTGCTCC TGGTCTCTTC TGAATCTTTG GGTCAGTGGT TCTCAACCCT GGCTGCAGAG 1500
AATTAGAGTC ACTTGCTGGG GGCGGATGGG CTGGGGAGTT ATATGCCAAA ACTTGCGCCT 1560
ATTTCCCTAA AGTTCGGATT TAATTGGTCT GCCCTGGGGC ATAAACAGTA TTGCTATTTA 1620
AAAATCAGGC TTCCCCTGGT GACTGTAATG TGCTACCAGG GCTATGAAGC ACTGATCTGG 1680
GGTCTTGGGG AATTATGGTT TGAGAAGCAC AAACTCAGAT ATCACTCTTT TAGGGGTTAG 1740
ACCTTGGGAG CTCATCTGTG TGTCCCCTCC CTAGTGGCCT AATTTCCCTA GGTCTCGGTA 1800
GGAGGAGGAC CTTGGGGGAA GATTCTCTTG CCTTAGCAGG AGAGAAGCCT ATAGCTAATG 1860
AGACATGGAG CAAAAGAGAA GAAGGGAGAG GGAGAAACTA AAAGAAGGAT AAATGGACAA 1920
AGAAAGAAGG AAGGGCAAGA AAACAGTAGA AAAATAGTGG CTGGGTAGAG GCCCAGAAGG 1980
ACCACCATAA CTGTTCAGGT CTCAGGACCA AAGCTGGACA TTGGGAGCAA ATCCCCGTTC 2040
CCTGGGAGGG GAATTCTCTA GCTGCCCTGA GATCAGCTGG AGAAGTCAAG CCCTGCGGGG 2100
AAGGCGGCCT GCGGTGAATT TCGTGCTTAC 2130
|
